MedPath

AK-PENTOLATE

AK-PENTOLATE™ Cyclopentolate Hydrochloride Ophthalmic Solution, USP -Sterile

Approved
Approval ID

1d97ba11-5b69-4ba3-9310-fa000183de43

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 1, 2010

Manufacturers
FDA

Rebel Distributors Corp.

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cyclopentolate Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-883
Application NumberANDA040164
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cyclopentolate Hydrochloride
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateMarch 9, 2009
FDA Product Classification

INGREDIENTS (8)

Cyclopentolate HydrochlorideActive
Quantity: 10 mg in 1 mL
Code: 736I6971TE
Classification: ACTIB
Benzalkonium ChlorideInactive
Quantity: 0.1 mg in 1 mL
Code: F5UM2KM3W7
Classification: IACT
Boric AcidInactive
Code: R57ZHV85D4
Classification: IACT
Edetate DisodiumInactive
Code: 7FLD91C86K
Classification: IACT
Potassium ChlorideInactive
Code: 660YQ98I10
Classification: IACT
WaterInactive
Code: 059QF0KO0R
Classification: IACT
Sodium CarbonateInactive
Code: 45P3261C7T
Classification: IACT
Hydrochloric AcidInactive
Code: QTT17582CB
Classification: IACT

Drug Labeling Information

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 3/9/2009

Akorn
Lake Forest, IL 60045

CP00N

Revised 05/08

Repackaged by:

Rebel Distributors Corp.

Thousand Oaks, CA 91320

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AK-PENTOLATE - FDA Drug Approval Details